Related Experiment Video
Updated: Feb 9, 2026

07:13
Platelet-based Detection of Nitric Oxide in Blood by Measuring VASP Phosphorylation
Published on: January 7, 2019
8.5K
[Endothelin and nitric oxide in newborn kidney]
M Baumert1, K Sodowski, J Sikora
1Kliniki Neonatologii Katedry Ginekologii i Połoznictwa Slaskiej Akademii Medycznej w Katowicach.
Summary
This review explores how endothelin and nitric oxide impact newborn kidney endothelial cell function. Understanding these vasoactive substances is crucial for neonatal kidney health.
Area of Science:
- Nephrology
- Vascular Biology
- Neonatal Physiology
Context:
- Endothelial cells in the kidney play a vital role in regulating renal function, particularly in newborns.
- Vasoactive substances like endothelin and nitric oxide are critical modulators of vascular tone and endothelial function.
- Neonatal kidney development is a sensitive period where vascular regulation is still maturing.
Purpose:
- To review the distinct roles of endothelin and nitric oxide in modulating kidney endothelial cell functions in newborns.
- To elucidate the mechanisms by which these vasoactive substances influence neonatal renal hemodynamics and cellular processes.
- To provide a comprehensive overview of the current understanding of endothelin and nitric oxide in the context of neonatal kidney physiology.
Summary:
- Endothelin is a potent vasoconstrictor that influences renal blood flow and glomerular filtration rate in neonates.
- Nitric oxide acts as a vasodilator, promoting renal blood flow and protecting endothelial cells from injury in the developing kidney.
- The balance between endothelin and nitric oxide is critical for maintaining appropriate kidney function during the neonatal period.
Impact:
- This review highlights the importance of vasoactive substance regulation for neonatal kidney health.
- Findings can inform potential therapeutic strategies targeting endothelin or nitric oxide pathways to manage neonatal kidney disorders.
- Understanding these mechanisms contributes to the broader field of developmental nephrology and vascular biology.
Related Concept Videos
Nitric Oxide Signaling Pathway
6.3K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.3K
Oxidation Numbers
42.9K
In redox reactions, the transfer of electrons occurs between reacting species. Electron transfer is described by a hypothetical number called the oxidation number (or oxidation state). It represents the effective charge of an atom or element, which is assigned using a set of rules.
42.9K
Kidney Structure
75.4K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
75.4K
Pyruvate Oxidation
169.1K
After glycolysis, the charged pyruvate molecules enter the mitochondria via active transport and undergo three enzymatic reactions. These reactions ensure that pyruvate can enter the next metabolic pathway so that energy stored in the pyruvate molecules can be harnessed by the cells.
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
169.1K
Oxidation-Reduction Reactions
75.8K
Oxidation–Reduction Reactions
75.8K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
478
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
478

